Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shiladitya Sengupta, Ph.D.

Profile Picture
Other Positions


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA236702 (SENGUPTA, SHILADITYA) Apr 1, 2019 - Mar 31, 2024
    Whitlockite nanoparticle-based immunotherapy for bone metastasis
    Role: Principal Investigator
  2. U01CA214411 (SENGUPTA, SHILADITYA) Sep 21, 2017 - Jul 31, 2022
    Engineering personalized micro-tumor ecosystems
    Role: Co-Principal Investigator
  3. R21CA186009 (SENGUPTA, SHILADITYA) May 16, 2014 - Apr 30, 2016
    Engineering a supramolecular platinum nanoparticle for pediatric cancer
    Role: Principal Investigator
  4. R01CA135242 (SENGUPTA, SHILADITYA) Mar 19, 2010 - Dec 31, 2014
    Multifunctional nanoparticles for targeting aberrant tumorigenic pathways
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nandi UK, Patel P, Moid M, Nandi MK, Sengupta S, Karmakar S, Maiti PK, Dasgupta C, Maitra Bhattacharyya S. Thermodynamics and its correlation with dynamics in a mean-field model and pinned systems: A comparative study using two different methods of entropy calculation. J Chem Phys. 2022 Jan 07; 156(1):014503. PMID: 34998317.
    Citations:    Fields:    
  2. Saha T, Dash C, Jayabalan R, Khiste S, Kulkarni A, Kurmi K, Mondal J, Majumder PK, Bardia A, Jang HL, Sengupta S. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat Nanotechnol. 2022 01; 17(1):98-106. PMID: 34795441.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  3. Saha T, Mondal J, Khiste S, Lusic H, Hu ZW, Jayabalan R, Hodgetts KJ, Jang H, Sengupta S, Eunice Lee S, Park Y, Lee LP, Goldman A. Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer. Nanophotonics. 2021 Sep; 10(12):3063-3073. PMID: 34589378.
  4. Dash C, Saha T, Sengupta S, Jang HL. Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype. Int J Mol Sci. 2021 Jun 07; 22(11). PMID: 34200503.
    Citations: 1     Fields:    Translation:HumansCells
  5. Namgung B, Ravi K, Vikraman PP, Sengupta S, Jang HL. Engineered cell-laden alginate microparticles for 3D culture. Biochem Soc Trans. 2021 04 30; 49(2):761-773. PMID: 33860783.
    Citations: 3     Fields:    Translation:HumansCells
  6. Chung I, Zhou K, Barrows C, Banyard J, Wilson A, Rummel N, Mizokami A, Basu S, Sengupta P, Shaikh B, Sengupta S, Bielenberg DR, Zetter BR. Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer. Front Oncol. 2020; 10:594141. PMID: 33738243.
    Citations: 1     
  7. Bacolla A, Sengupta S, Ye Z, Yang C, Mitra J, De-Paula RB, Hegde ML, Ahmed Z, Mort M, Cooper DN, Mitra S, Tainer JA. Heritable pattern of oxidized DNA base repair coincides with pre-targeting of repair complexes to open chromatin. Nucleic Acids Res. 2021 01 11; 49(1):221-243. PMID: 33300026.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  8. Freag MS, Namgung B, Reyna Fernandez ME, Gherardi E, Sengupta S, Jang HL. Human Nonalcoholic Steatohepatitis on a Chip. Hepatol Commun. 2021 02; 5(2):217-233. PMID: 33553970.
    Citations: 9     Fields:    Translation:HumansCells
  9. Smalley M, Natarajan SK, Mondal J, Best D, Goldman D, Shanthappa B, Pellowe M, Dash C, Saha T, Khiste S, Ramadurai N, Eton EO, Smalley JL, Brown A, Thayakumar A, Rahman M, Arai K, Kohandel M, Sengupta S, Goldman A. Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer. Cancer Res. 2020 12 01; 80(23):5355-5366. PMID: 33077554.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  10. Tong H, Sengupta S, Tanaka H. Emergent solidity of amorphous materials as a consequence of mechanical self-organisation. Nat Commun. 2020 Sep 25; 11(1):4863. PMID: 32978393.
    Citations: 1     Fields:    
  11. Gupta N, Ansari A, Dhoke GV, Chilamari M, Sivaccumar J, Kumari S, Chatterjee S, Goyal R, Dutta PK, Samarla M, Mukherjee M, Sarkar A, Mandal SK, Rai V, Biswas G, Sengupta A, Roy S, Roy M, Sengupta S. Author Correction: Computationally designed antibody-drug conjugates self-assembled via affinity ligands. Nat Biomed Eng. 2020 Jan; 4(1):131. PMID: 31900467.
    Citations:    Fields:    
  12. Gupta N, Ansari A, Dhoke GV, Chilamari M, Sivaccumar J, Kumari S, Chatterjee S, Goyal R, Dutta PK, Samarla M, Mukherjee M, Sarkar A, Mandal SK, Rai V, Biswas G, Sengupta A, Roy S, Roy M, Sengupta S. Computationally designed antibody-drug conjugates self-assembled via affinity ligands. Nat Biomed Eng. 2019 11; 3(11):917-929. PMID: 31686001.
    Citations: 5     Fields:    Translation:AnimalsCells
  13. Goldman A, Khiste S, Freinkman E, Dhawan A, Majumder B, Mondal J, Pinkerton AB, Eton E, Medhi R, Chandrasekar V, Rahman MM, Ichimura T, Gopinath KS, Majumder P, Kohandel M, Sengupta S. Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance. Sci Signal. 2019 08 20; 12(595). PMID: 31431543.
    Citations: 22     Fields:    Translation:HumansCells
  14. Jang HL, Sengupta S. Transcellular transfer of nanomedicine. Nat Nanotechnol. 2019 08; 14(8):731-732. PMID: 31263193.
    Citations: 5     Fields:    Translation:HumansAnimals
  15. Connor Y, Tekleab Y, Tekleab S, Nandakumar S, Bharat D, Sengupta S. A mathematical model of tumor-endothelial interactions in a 3D co-culture. Sci Rep. 2019 06 10; 9(1):8429. PMID: 31182723.
    Citations: 3     Fields:    Translation:HumansCells
  16. Bandaru P, Chu D, Sun W, Lasli S, Zhao C, Hou S, Zhang S, Ni J, Cefaloni G, Ahadian S, Dokmeci MR, Sengupta S, Lee J, Khademhosseini A. A Microfabricated Sandwiching Assay for Nanoliter and High-Throughput Biomarker Screening. Small. 2019 04; 15(15):e1900300. PMID: 30884183.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  17. Kulkarni A, Chandrasekar V, Natarajan SK, Ramesh A, Pandey P, Nirgud J, Bhatnagar H, Ashok D, Ajay AK, Sengupta S. A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. Nat Biomed Eng. 2018 08; 2(8):589-599. PMID: 30956894.
    Citations: 30     Fields:    Translation:AnimalsCells
  18. Ghosh S, Sinha M, Bhattacharyya A, Sadhasivam S, Megha J, Reddy S, Saini S, Singh H, Kumar D, Kaur SP, Mishra M, Usharani D, Ghosh S, Sengupta S. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne. J Invest Dermatol. 2018 06; 138(6):1400-1408. PMID: 29409921.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  19. Sengupta S. Cancer Nanomedicine: Lessons for Immuno-Oncology. Trends Cancer. 2017 08; 3(8):551-560. PMID: 28780932.
    Citations: 12     Fields:    Translation:Humans
  20. Gupta N, Kancharla J, Kaushik S, Ansari A, Hossain S, Goyal R, Pandey M, Sivaccumar J, Hussain S, Sarkar A, Sengupta A, Mandal SK, Roy M, Sengupta S. Development of a facile antibody-drug conjugate platform for increased stability and homogeneity. Chem Sci. 2017 Mar 01; 8(3):2387-2395. PMID: 28451344.
    Citations: 7     
  21. Calibasi Kocal G, Güven S, Foygel K, Goldman A, Chen P, Sengupta S, Paulmurugan R, Baskin Y, Demirci U. Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Sci Rep. 2016 12 02; 6:38221. PMID: 27910892.
    Citations: 13     Fields:    Translation:HumansCells
  22. Kulkarni A, Natarajan SK, Chandrasekar V, Pandey PR, Sengupta S. Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy. ACS Nano. 2016 Oct 25; 10(10):9227-9242. PMID: 27656909.
    Citations: 9     Fields:    
  23. Kulkarni A, Pandey P, Rao P, Mahmoud A, Goldman A, Sabbisetti V, Parcha S, Natarajan SK, Chandrasekar V, Dinulescu D, Roy S, Sengupta S. Algorithm for Designing Nanoscale Supramolecular Therapeutics with Increased Anticancer Efficacy. ACS Nano. 2016 09 27; 10(9):8154-68. PMID: 27452234.
    Citations: 4     Fields:    Translation:Cells
  24. Goldman A, Kulkarni A, Kohandel M, Pandey P, Rao P, Natarajan SK, Sabbisetti V, Sengupta S. Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer. ACS Nano. 2016 06 28; 10(6):5823-34. PMID: 27257911.
    Citations: 23     Fields:    
  25. Molavian HR, Goldman A, Phipps CJ, Kohandel M, Wouters BG, Sengupta S, Sivaloganathan S. Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects. Sci Rep. 2016 06 09; 6:27439. PMID: 27278439.
    Citations: 12     Fields:    Translation:HumansCells
  26. Boareto M, Jolly MK, Goldman A, Pietilä M, Mani SA, Sengupta S, Ben-Jacob E, Levine H, Onuchic JN. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface. 2016 05; 13(118). PMID: 27170649.
    Citations: 49     Fields:    Translation:HumansCells
  27. Kulkarni AA, Vijaykumar VE, Natarajan SK, Sengupta S, Sabbisetti VS. Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer. Nanomedicine. 2016 10; 12(7):1853-1861. PMID: 27084552.
    Citations: 8     Fields:    Translation:HumansCells
  28. Kulkarni A, Rao P, Natarajan S, Goldman A, Sabbisetti VS, Khater Y, Korimerla N, Chandrasekar V, Mashelkar RA, Sengupta S. Reporter nanoparticle that monitors its anticancer efficacy in real time. Proc Natl Acad Sci U S A. 2016 Apr 12; 113(15):E2104-13. PMID: 27036008.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  29. Sadhasivam, S., Sinha, M., Saini, S., Kaur, S.P., Gupta, T., Sengupta, S., Ghosh, S. and Sardana, K. . Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes. Dermatologic Therapy, 29: 451-454. 2016; (29):451-454.
  30. Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, Gadish O, Sabbisetti V, Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, R Edelman E, Sengupta S. Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nat Commun. 2015 Dec 16; 6:8671. PMID: 26669454.
    Citations: 33     Fields:    Translation:HumansCells
  31. Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani M, Brijwani N, Pinto DD, Prasath A, Shanthappa BU, Thayakumar A, Surendran R, Babu GK, Shenoy AM, Kuriakose MA, Bergthold G, Horowitz P, Loda M, Beroukhim R, Agarwal S, Sengupta S, Sundaram M, Majumder PK. Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat Commun. 2015 Feb 27; 6:6169. PMID: 25721094.
    Citations: 108     Fields:    Translation:Humans
  32. Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat Commun. 2015 Feb 11; 6:6139. PMID: 25669750.
    Citations: 113     Fields:    Translation:HumansAnimalsCells
  33. Pandey A, Sarangi S, Chien K, Sengupta P, Papa AL, Basu S, Sengupta S. Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery. Nanotechnology. 2014 Nov 07; 25(44):445101. PMID: 25302488.
    Citations: 5     Fields:    Translation:AnimalsCells
  34. Pandey A, Kulkarni A, Roy B, Goldman A, Sarangi S, Sengupta P, Phipps C, Kopparam J, Oh M, Basu S, Kohandel M, Sengupta S. Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy. Cancer Res. 2014 Feb 01; 74(3):675-685. PMID: 24121494.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  35. Kulkarni AA, Roy B, Rao PS, Wyant GA, Mahmoud A, Ramachandran M, Sengupta P, Goldman A, Kotamraju VR, Basu S, Mashelkar RA, Ruoslahti E, Dinulescu DM, Sengupta S. Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy. Cancer Res. 2013 Dec 01; 73(23):6987-97. PMID: 24121488.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  36. Papa AL, Sidiqui A, Balasubramanian SU, Sarangi S, Luchette M, Sengupta S, Harfouche R. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic. Cell Oncol (Dordr). 2013 Dec; 36(6):449-57. PMID: 24081907.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  37. Sengupta S, Kulkarni A. Design principles for clinical efficacy of cancer nanomedicine: a look into the basics. ACS Nano. 2013 Apr 23; 7(4):2878-82. PMID: 23607425.
    Citations: 12     Fields:    Translation:Humans
  38. Sarangi S, Pandey A, Papa AL, Sengupta P, Kopparam J, Dadwal U, Basu S, Sengupta S. P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer. Med Oncol. 2013; 30(2):567. PMID: 23568163.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  39. Papa AL, Basu S, Sengupta P, Banerjee D, Sengupta S, Harfouche R. Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells. BMC Cancer. 2012 Sep 22; 12:419. PMID: 22998550.
    Citations: 15     Fields:    Translation:HumansCells
  40. Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity. Proc Natl Acad Sci U S A. 2012 Jul 10; 109(28):11294-9. PMID: 22733767.
    Citations: 33     Fields:    Translation:AnimalsCells
  41. Paraskar A, Soni S, Roy B, Papa AL, Sengupta S. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy. Nanotechnology. 2012 Feb 24; 23(7):075103. PMID: 22275055.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  42. Piecewicz SM, Pandey A, Roy B, Xiang SH, Zetter BR, Sengupta S. Insulin-like growth factors promote vasculogenesis in embryonic stem cells. PLoS One. 2012; 7(2):e32191. PMID: 22363814.
    Citations: 22     Fields:    Translation:AnimalsCells
  43. Roy RS, Roy B, Sengupta S. Emerging technologies for enabling proangiogenic therapy. Nanotechnology. 2011 Dec 09; 22(49):494004. PMID: 22101316.
    Citations: 3     Fields:    Translation:HumansAnimals
  44. Paraskar A, Soni S, Basu S, Amarasiriwardena CJ, Lupoli N, Srivats S, Roy RS, Sengupta S. Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy. Nanotechnology. 2011 Jul 01; 22(26):265101. PMID: 21576779.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  45. Sengupta P, Basu S, Sengupta S. Cancer, signal transduction and nanotechnology. Curr Drug Deliv. 2011 May; 8(3):254-60. PMID: 21291374.
    Citations:    Fields:    Translation:HumansAnimalsCells
  46. Banerjee D, Harfouche R, Sengupta S. Nanotechnology-mediated targeting of tumor angiogenesis. Vasc Cell. 2011 Jan 31; 3(1):3. PMID: 21349160.
    Citations: 26     
  47. Piecewicz S, Sengupta S. The dynamic glycome microenvironment and stem cell differentiation into vasculature. Stem Cells Dev. 2011 May; 20(5):749-58. PMID: 21091341.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  48. Banerjee D, Sengupta S. Nanoparticles in cancer chemotherapy. Prog Mol Biol Transl Sci. 2011; 104:489-507. PMID: 22093227.
    Citations: 9     Fields:    Translation:Humans
  49. Sinha Roy R, Soni S, Harfouche R, Vasudevan PR, Holmes O, de Jonge H, Rowe A, Paraskar A, Hentschel DM, Chirgadze D, Blundell TL, Gherardi E, Mashelkar RA, Sengupta S. Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis. Proc Natl Acad Sci U S A. 2010 Aug 03; 107(31):13608-13. PMID: 20639469.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  50. Paraskar AS, Soni S, Chin KT, Chaudhuri P, Muto KW, Berkowitz J, Handlogten MW, Alves NJ, Bilgicer B, Dinulescu DM, Mashelkar RA, Sengupta S. Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy. Proc Natl Acad Sci U S A. 2010 Jul 13; 107(28):12435-40. PMID: 20616005.
    Citations: 41     Fields:    Translation:Animals
  51. Agarwal S, Dugar D, Sengupta S. Ranking chemical structures for drug discovery: a new machine learning approach. J Chem Inf Model. 2010 May 24; 50(5):716-31. PMID: 20387860.
    Citations: 26     Fields:    Translation:Cells
  52. Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S. Shape effect of carbon nanovectors on angiogenesis. ACS Nano. 2010 Jan 26; 4(1):574-82. PMID: 20043662.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  53. Chaudhuri P, Soni S, Sengupta S. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma. Nanotechnology. 2010 Jan 15; 21(2):025102. PMID: 19955607.
    Citations: 17     Fields:    Translation:AnimalsCells
  54. Basu S, Chaudhuri P, Sengupta S. Targeting oncogenic signaling pathways by exploiting nanotechnology. Cell Cycle. 2009 Nov 01; 8(21):3480-7. PMID: 19823014.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  55. Harfouche R, Hentschel DM, Piecewicz S, Basu S, Print C, Eavarone D, Kiziltepe T, Sasisekharan R, Sengupta S. Glycome and transcriptome regulation of vasculogenesis. Circulation. 2009 Nov 10; 120(19):1883-1892. PMID: 19858418.
    Citations: 9     Fields:    Translation:AnimalsCells
  56. Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S. Fullerenol-cytotoxic conjugates for cancer chemotherapy. ACS Nano. 2009 Sep 22; 3(9):2505-14. PMID: 19681636.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  57. Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S. Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):7957-61. PMID: 19383798.
    Citations: 34     Fields:    Translation:HumansAnimalsCells
  58. Harfouche R, Basu S, Soni S, Hentschel DM, Mashelkar RA, Sengupta S. Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis. Angiogenesis. 2009; 12(4):325-38. PMID: 19685150.
    Citations: 26     Fields:    Translation:HumansAnimalsCells
  59. Sengupta S, Sasisekharan R. Exploiting nanotechnology to target cancer. Br J Cancer. 2007 May 07; 96(9):1315-9. PMID: 17406364.
    Citations: 13     Fields:    Translation:Humans
  60. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer. 2007 Feb 15; 109(4):703-12. PMID: 17219447.
    Citations: 13     Fields:    Translation:HumansCells
  61. Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS, Roychoudhury S. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis. 2007 Jan; 28(1):81-92. PMID: 16777988.
    Citations: 54     Fields:    Translation:HumansCells
  62. Chakrabarti S, Sengupta S, Sengupta A, Basak SN, Roy A, Panda C, Roychoudhury S. Genomic instabilities in squamous cell carcinoma of head and neck from the Indian population. Mol Carcinog. 2006 Apr; 45(4):270-7. PMID: 16402388.
    Citations: 2     Fields:    Translation:HumansCells
  63. Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005 Jul 28; 436(7050):568-72. PMID: 16049491.
    Citations: 223     Fields:    Translation:HumansAnimalsCells
  64. Sengupta S, Sellers LA, Gherardi E, Sasisekharan R, Fan TP. Nitric oxide modulates hepatocyte growth factor/scatter factor-induced angiogenesis. Angiogenesis. 2004; 7(4):285-94. PMID: 15886872.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  65. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RN, Sasisekharan R, Fan TP. Modulating angiogenesis: the yin and the yang in ginseng. Circulation. 2004 Sep 07; 110(10):1219-25. PMID: 15337705.
    Citations: 84     Fields:    Translation:HumansAnimalsCells
  66. Sengupta S, Kiziltepe T, Sasisekharan R. A dual-color fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules. FASEB J. 2004 Oct; 18(13):1565-7. PMID: 15333517.
    Citations: 2     Fields:    Translation:HumansCells
  67. Qi Y, Zhao G, Liu D, Shriver Z, Sundaram M, Sengupta S, Venkataraman G, Langer R, Sasisekharan R. Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route. Proc Natl Acad Sci U S A. 2004 Jun 29; 101(26):9867-72. PMID: 15226520.
    Citations: 14     Fields:    Translation:AnimalsCells
  68. Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis. Cancer Res. 2003 Dec 01; 63(23):8351-9. PMID: 14678996.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  69. Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R, Freeman TC, Tom BD, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print CG. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J. 2004 Jan; 18(1):188-90. PMID: 14630703.
    Citations: 9     Fields:    Translation:HumansCells
  70. Sengupta S, Sellers LA, Li RC, Gherardi E, Zhao G, Watson N, Sasisekharan R, Fan TP. Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. Circulation. 2003 Jun 17; 107(23):2955-61. PMID: 12782568.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  71. Sengupta S, Sellers LA, Matheson HB, Fan TP. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol. 2003 May; 139(2):219-31. PMID: 12770927.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  72. Sengupta S, Gherardi E, Sellers LA, Wood JM, Sasisekharan R, Fan TP. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2003 Jan 01; 23(1):69-75. PMID: 12524227.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  73. Sengupta S, Tyagi P, Chandra S, Kochupillai V, Gupta SK. . Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase II inhibitor. Pharmacology. 2001; 3(62):163-71.
  74. Sengupta S, Tyagi P, Velpandian T, Gupta YK, Gupta SK. . Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res. 2000 Nov;42(5):459-64. 2000; 5(42):459-64.
  75. Tyagi P,Sengupta S, Velpandian T,Gupta YK,Kochupillai V, Gupta SK. Evaluation of the Antitumour Activity of Liposomal Formulations of Etoposide Against Choriocarcinoma Xenografts in Balb/cnu/nu Mice. Pharmacy and Pharmacology Communications. 1999; (5):595-598.
  76. Gupta SK, Bhardwaj RK, Tyagi P, Sengupta S, Velpandian T. . Anti-inflammatory activity and pharmacokinetic profile of a new parenteral formulation of nimesulide. Pharmacol Res. 1999; 2(39):137-41.
  77. Gupta SK, Velpandian T, Mathur P, Sengupta S. . Comparative analgesic activity of nimesulide and diclofenac by intramuscular route: correlation with pharmacokinetic profile of nimesulide. Pharmacology. 1998; 3(56):137-43.
  78. Sengupta S, Velpandian T, Kabir SR, Gupta SK. . Analgesic efficacy and pharmacokinetics of topical nimesulide gel in healthy human volunteers: double-blind comparison with piroxicam, diclofenac and placebo. Eur J Clin Pharmacol. 1998; 7(54):541-7.
  79. Sengupta S, Velpandian T, Sapra P, Mathur P, Gupta SK. . Comparative analgesic efficacy of nimesulide and diclofenac gels after topical application on the skin. Skin Pharmacol Appl Skin Physiol. 1998; 4(11):273-8.
  80. Gupta SK, Prakash J, Awor L, Joshi S, Velpandian T, Sengupta S. Anti-inflammatory activity of topical nimesulide gel in various experimental models. Inflamm Res. 1996; 12(45):590-2.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sengupta's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (410)
Co-Authors (23)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.